Tianjin Minxiang Biomedical Co.，Ltd. (stock code: 834738) was founded in 2005 with registered capital of￥67.3 million. It is a high-tech enterprise that engages in researching, developing and manufacturing biological medicines, chemical raw medicines, preparations, intermediates, and new drugs.

The company has many R&D staffs in chemical synthesis, development of chemical technology, detection and quality analysis. Moreover, the company has hired some experts to offering guidance in the fields of information collection, R&D, and scientific research cooperation.

Insisting on technology innovation system of "combination of production, teaching and research", the company has cooperated with excellent experts and technicians of well-known universities for developing pharmaceutical raw materials and intermediates.

The company insists on strategic thinking of "taking processional scientific research and development as core, promoting comprehensive competitiveness of enterprise", and it encourages and supports the R&D of new products and technological innovation. Minxiang unremittingly increases investment in scientific research to promote R&D capability of the enterprise.